AU2017308587A1 - Process for providing protective therapy for biological tissues or fluids - Google Patents
Process for providing protective therapy for biological tissues or fluids Download PDFInfo
- Publication number
- AU2017308587A1 AU2017308587A1 AU2017308587A AU2017308587A AU2017308587A1 AU 2017308587 A1 AU2017308587 A1 AU 2017308587A1 AU 2017308587 A AU2017308587 A AU 2017308587A AU 2017308587 A AU2017308587 A AU 2017308587A AU 2017308587 A1 AU2017308587 A1 AU 2017308587A1
- Authority
- AU
- Australia
- Prior art keywords
- target
- tissue
- target tissue
- energy source
- para
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 71
- 239000012530 fluid Substances 0.000 title claims abstract description 64
- 230000008569 process Effects 0.000 title claims abstract description 55
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 12
- 230000001681 protective effect Effects 0.000 title claims abstract description 11
- 230000001684 chronic effect Effects 0.000 claims abstract description 40
- 208000037821 progressive disease Diseases 0.000 claims abstract description 36
- 230000006378 damage Effects 0.000 claims abstract description 32
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 21
- 230000000069 prophylactic effect Effects 0.000 claims abstract description 5
- 238000002604 ultrasonography Methods 0.000 claims description 71
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 56
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 56
- 230000004913 activation Effects 0.000 claims description 46
- 210000001124 body fluid Anatomy 0.000 claims description 18
- 230000000451 tissue damage Effects 0.000 claims description 15
- 231100000827 tissue damage Toxicity 0.000 claims description 15
- 230000004936 stimulating effect Effects 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 description 212
- 238000011282 treatment Methods 0.000 description 129
- 238000001994 activation Methods 0.000 description 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 39
- 201000010099 disease Diseases 0.000 description 38
- 230000000694 effects Effects 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 31
- 210000001525 retina Anatomy 0.000 description 28
- 230000002207 retinal effect Effects 0.000 description 28
- 238000010521 absorption reaction Methods 0.000 description 26
- 230000003287 optical effect Effects 0.000 description 25
- 108090000623 proteins and genes Proteins 0.000 description 24
- 230000008901 benefit Effects 0.000 description 22
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 20
- 230000005670 electromagnetic radiation Effects 0.000 description 18
- 230000006870 function Effects 0.000 description 18
- 230000007246 mechanism Effects 0.000 description 18
- 238000010438 heat treatment Methods 0.000 description 16
- 230000005855 radiation Effects 0.000 description 16
- 230000005451 protein repair Effects 0.000 description 14
- 230000008439 repair process Effects 0.000 description 14
- 208000017442 Retinal disease Diseases 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 12
- 210000000624 ear auricle Anatomy 0.000 description 12
- 230000007774 longterm Effects 0.000 description 12
- 230000002159 abnormal effect Effects 0.000 description 11
- 230000002411 adverse Effects 0.000 description 11
- 238000009792 diffusion process Methods 0.000 description 11
- 230000005856 abnormality Effects 0.000 description 10
- 230000003915 cell function Effects 0.000 description 10
- 239000000835 fiber Substances 0.000 description 10
- 230000035515 penetration Effects 0.000 description 10
- 230000000649 photocoagulation Effects 0.000 description 10
- 102000004127 Cytokines Human genes 0.000 description 9
- 108090000695 Cytokines Proteins 0.000 description 9
- 206010064930 age-related macular degeneration Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 208000002780 macular degeneration Diseases 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000013459 approach Methods 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 230000004393 visual impairment Effects 0.000 description 8
- 206010012689 Diabetic retinopathy Diseases 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 230000005779 cell damage Effects 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000013307 optical fiber Substances 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 238000001126 phototherapy Methods 0.000 description 7
- 208000010412 Glaucoma Diseases 0.000 description 6
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 208000036971 interstitial lung disease 2 Diseases 0.000 description 6
- 210000001328 optic nerve Anatomy 0.000 description 6
- 230000004304 visual acuity Effects 0.000 description 6
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 238000013532 laser treatment Methods 0.000 description 5
- 231100000518 lethal Toxicity 0.000 description 5
- 230000001665 lethal effect Effects 0.000 description 5
- 230000000324 neuroprotective effect Effects 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 5
- 238000011476 stem cell transplantation Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- 206010025421 Macule Diseases 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 208000038016 acute inflammation Diseases 0.000 description 4
- 230000006022 acute inflammation Effects 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 208000037887 cell injury Diseases 0.000 description 4
- 208000037976 chronic inflammation Diseases 0.000 description 4
- 230000006020 chronic inflammation Effects 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 230000000750 progressive effect Effects 0.000 description 4
- 238000009163 protein therapy Methods 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 230000004243 retinal function Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 3
- 206010057430 Retinal injury Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 229940124599 anti-inflammatory drug Drugs 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000001415 gene therapy Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000014951 hematologic disease Diseases 0.000 description 3
- 239000003018 immunosuppressive agent Substances 0.000 description 3
- 229940124589 immunosuppressive drug Drugs 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 238000011268 retreatment Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000003098 Ganglion Cysts Diseases 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000001344 Macular Edema Diseases 0.000 description 2
- 206010025415 Macular oedema Diseases 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- 208000005400 Synovial Cyst Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000010398 acute inflammatory response Effects 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 201000011190 diabetic macular edema Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000009395 genetic defect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000004410 intraocular pressure Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004880 lymph fluid Anatomy 0.000 description 2
- 201000010230 macular retinal edema Diseases 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000003818 metabolic dysfunction Effects 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 230000009826 neoplastic cell growth Effects 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 230000004768 organ dysfunction Effects 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000246 remedial effect Effects 0.000 description 2
- 210000001533 respiratory mucosa Anatomy 0.000 description 2
- 210000003994 retinal ganglion cell Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000033379 Chorioretinopathy Diseases 0.000 description 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031074 Reinjury Diseases 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000027073 Stargardt disease Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000010001 cellular homeostasis Effects 0.000 description 1
- 230000004637 cellular stress Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 230000009433 disease-worsening effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000004258 retinal degeneration Effects 0.000 description 1
- 230000004262 retinal health Effects 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 201000003772 severe nonproliferative diabetic retinopathy Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 230000007853 structural degeneration Effects 0.000 description 1
- 210000002301 subretinal fluid Anatomy 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000008542 thermal sensitivity Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000001585 trabecular meshwork Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/041—Capsule endoscopes for imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/233—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the nose, i.e. nasoscopes, e.g. testing of patency of Eustachian tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/267—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the respiratory tract, e.g. laryngoscopes, bronchoscopes
- A61B1/2676—Bronchoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
- A61B1/2736—Gastroscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00137—Details of operation mode
- A61B2017/00154—Details of operation mode pulsed
- A61B2017/00172—Pulse trains, bursts, intermittent continuous operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00494—Stomach, intestines or bowel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00589—Coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0604—Lungs and/or airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0607—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0642—Irradiating part of the body at a certain distance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Radiation-Therapy Devices (AREA)
- Laser Surgery Devices (AREA)
- Electrotherapy Devices (AREA)
- Surgical Instruments (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/232,320 | 2016-08-09 | ||
| US15/232,320 US9962291B2 (en) | 2012-05-25 | 2016-08-09 | System and process for neuroprotective therapy for glaucoma |
| US15/583,096 | 2017-05-01 | ||
| US15/583,096 US10953241B2 (en) | 2012-05-25 | 2017-05-01 | Process for providing protective therapy for biological tissues or fluids |
| PCT/US2017/044319 WO2018031255A1 (fr) | 2016-08-09 | 2017-07-28 | Processus destiné à fournir une thérapie protectrice pour des tissus ou de fluides biologiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2017308587A1 true AU2017308587A1 (en) | 2019-01-17 |
Family
ID=61162420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017308587A Abandoned AU2017308587A1 (en) | 2016-08-09 | 2017-07-28 | Process for providing protective therapy for biological tissues or fluids |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3496810A4 (fr) |
| JP (1) | JP2019524179A (fr) |
| CN (1) | CN109562272A (fr) |
| AU (1) | AU2017308587A1 (fr) |
| BR (1) | BR112019001348A2 (fr) |
| CA (1) | CA3030483A1 (fr) |
| WO (1) | WO2018031255A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112041025B (zh) * | 2019-06-17 | 2021-09-03 | 浙江莱恩海思医疗科技有限公司 | 用于进行头部照射的光治疗设备及光治疗仪及其治疗方法 |
| EP4185376A4 (fr) * | 2020-08-04 | 2023-11-15 | Ojai Retinal Technology, LLC | Système et procédé de prévention ou de traitement de la maladie d'alzheimer et d'autres maladies neurodégénératives |
| CN118949276B (zh) * | 2024-09-19 | 2025-08-05 | 丹阳慧创医疗设备有限公司 | 一种经颅物理刺激装置 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02252469A (ja) * | 1989-03-27 | 1990-10-11 | Olympus Optical Co Ltd | 生体深部治療装置 |
| US6047216A (en) * | 1996-04-17 | 2000-04-04 | The United States Of America Represented By The Administrator Of The National Aeronautics And Space Administration | Endothelium preserving microwave treatment for atherosclerosis |
| WO2004033040A1 (fr) * | 2002-10-07 | 2004-04-22 | Palomar Medical Technologies, Inc. | Appareil de photobiostimulation |
| US20040202663A1 (en) * | 2003-01-28 | 2004-10-14 | Shanghai Sunway Biotech Co., Ltd. | Therapy for primary and metastatic cancers |
| CN1911192B (zh) * | 2006-07-29 | 2010-05-12 | 首都医科大学附属北京同仁医院 | 诱导视网膜热休克蛋白表达的装置及其应用 |
| WO2009088550A2 (fr) * | 2007-10-19 | 2009-07-16 | Lockheed Martin Corporation | Système et procédé de conditionnement de tissu animal par rayon laser |
| US9014801B2 (en) * | 2008-03-19 | 2015-04-21 | The Board Of Trustees Of The University Of Illinois | Electromagnetic field therapy delays cellular senescence and death by enhancement of the heat shock response |
| US8932196B2 (en) * | 2009-09-14 | 2015-01-13 | Minnesota Medical Physics Llc | Thermally assisted pulsed electro-magnetic field stimulation device and method for treatment of osteoarthritis |
| WO2012018385A2 (fr) * | 2010-08-02 | 2012-02-09 | Guided Therapy Systems, Llc | Système et méthode de traitement du cartilage |
| US20160220834A1 (en) * | 2011-11-16 | 2016-08-04 | Btl Holdings Limited | Method and system for skin treatment |
| US10953241B2 (en) * | 2012-05-25 | 2021-03-23 | Ojai Retinal Technology, Llc | Process for providing protective therapy for biological tissues or fluids |
| US9427602B2 (en) * | 2012-05-25 | 2016-08-30 | Ojai Retinal Technology, Llc | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair |
| WO2014040015A1 (fr) * | 2012-09-10 | 2014-03-13 | Dermal Photonics Corporation | Systèmes et procédés de traitement d'imperfections dermatologiques |
| WO2014070699A1 (fr) * | 2012-11-01 | 2014-05-08 | Seminex Corporation | Traitements de la peau au laser à intensité variable |
| CA2999499C (fr) * | 2013-03-15 | 2020-04-07 | Sonovia Holdings Llc | Transducteur ultrasonore et convertisseur de lumiere |
| CA2972416C (fr) * | 2015-01-28 | 2020-01-14 | Ojai Retinal Technology, Llc | Therapie electromagnetique pulsee et par ultrasons pour stimuler des proteines de choc thermique ciblees et faciliter une reparation de proteine |
-
2017
- 2017-07-28 CA CA3030483A patent/CA3030483A1/fr not_active Abandoned
- 2017-07-28 AU AU2017308587A patent/AU2017308587A1/en not_active Abandoned
- 2017-07-28 CN CN201780047506.XA patent/CN109562272A/zh active Pending
- 2017-07-28 BR BR112019001348A patent/BR112019001348A2/pt not_active Application Discontinuation
- 2017-07-28 WO PCT/US2017/044319 patent/WO2018031255A1/fr not_active Ceased
- 2017-07-28 JP JP2018565035A patent/JP2019524179A/ja active Pending
- 2017-07-28 EP EP17840010.7A patent/EP3496810A4/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BR112019001348A2 (pt) | 2019-04-30 |
| EP3496810A1 (fr) | 2019-06-19 |
| CN109562272A (zh) | 2019-04-02 |
| JP2019524179A (ja) | 2019-09-05 |
| CA3030483A1 (fr) | 2018-02-15 |
| EP3496810A4 (fr) | 2019-10-16 |
| WO2018031255A1 (fr) | 2018-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10953241B2 (en) | Process for providing protective therapy for biological tissues or fluids | |
| US10531908B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| US20170203132A1 (en) | System and process utilizing pulsed energy to treat biological tissue | |
| US9427602B2 (en) | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair | |
| US11033749B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| US10894169B2 (en) | System and method for preventing or treating Alzheimer's and other neurodegenerative diseases | |
| AU2020213374B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| CA3187662A1 (fr) | Systeme et procede de prevention ou de traitement de la maladie d'alzheimer et d'autres maladies neurodegeneratives | |
| JP2022119821A5 (fr) | ||
| AU2015380411B2 (en) | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair | |
| AU2018236202B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| AU2017308587A1 (en) | Process for providing protective therapy for biological tissues or fluids | |
| US20230103544A1 (en) | System and process for utilizing energy for neuroregeneration | |
| HK1262194A1 (en) | Process for providing protective therapy for biological tissues or fluids | |
| WO2024118164A1 (fr) | Système et procédé d'utilisation d'énergie pour la neurorégénération | |
| WO2018169560A1 (fr) | Système et procédé utilisant une énergie pulsée pour traiter un tissu biologique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |